1. Home
  2. ENTG vs EXAS Comparison

ENTG vs EXAS Comparison

Compare ENTG & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entegris Inc.

ENTG

Entegris Inc.

HOLD

Current Price

$89.12

Market Cap

13.1B

Sector

Industrials

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.08

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTG
EXAS
Founded
1966
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1B
11.0B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
ENTG
EXAS
Price
$89.12
$101.08
Analyst Decision
Buy
Buy
Analyst Count
8
20
Target Price
$98.25
$76.38
AVG Volume (30 Days)
2.8M
10.3M
Earning Date
10-30-2025
11-03-2025
Dividend Yield
0.45%
N/A
EPS Growth
26.59
N/A
EPS
1.90
N/A
Revenue
$3,222,508,000.00
$3,082,033,000.00
Revenue This Year
$0.27
$19.40
Revenue Next Year
$6.22
$13.51
P/E Ratio
$46.93
N/A
Revenue Growth
0.59
14.47
52 Week Low
$60.75
$38.81
52 Week High
$112.36
$101.87

Technical Indicators

Market Signals
Indicator
ENTG
EXAS
Relative Strength Index (RSI) 61.29 89.74
Support Level $72.23 $100.98
Resistance Level $75.13 $101.43
Average True Range (ATR) 3.62 2.25
MACD 2.05 0.53
Stochastic Oscillator 95.30 97.74

Price Performance

Historical Comparison
ENTG
EXAS

About ENTG Entegris Inc.

Entegris is a leading supplier of purification solutions and advanced materials. The vast majority of sales are to the semiconductor industry. The majority of revenue comes from semiconductor fabricators, but the company sells to all areas of the semiconductor manufacturing supply chain including equipment and engineering, chemicals and materials, and distributors. Entegris specializes in materials science and materials purity, both of which are crucial in the semiconductor manufacturing process.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: